Cable One Announces Quarterly Dividend and Commitment to Innovation

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Empowering Futures Through Education As a prominent philanthropist and former hedge fund manager, George Weiss continues to advocate for transformative education initiatives. His recent support for the expansion of the Say Yes Buffalo program into Niagara Falls is a testament to his lifelong commitment to ensuring that students have access to higher education and...

Introducing ROW 94 Full Proof Bourbon by Dierks Bentley The Full-Throttle, Already Gold Medal-Winner is ROW 94's Third Expression. Country music superstar Dierks Bentley is thrilled to launch the boldest and most authentic bourbon in the ROW 94 lineup, known as ROW 94 Full Proof. Available for $54.99 per 750ml, this exciting new release comes just a year after the...

ReShape Lifesciences Announces 1-for-58 Stock Consolidation Strategy In an effort to strengthen its presence in the market, ReShape Lifesciences Inc. (NASDAQ: RSLS), a frontrunner in weight loss and metabolic health solutions, has revealed a 1-for-58 reverse stock split of its common shares. This move, which has been approved by the company’s Board of Directors, will go...

Understanding Shareholder Rights As a shareholder of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), it’s imperative to be aware of your rights and the actions you can take to safeguard your interests. With the ever-evolving landscape of corporate governance, understanding the power of your voice becomes crucial. Immediate action is often necessary, as there may be limited...

Troilus Gold Corp. Secures $35 Million Loan Facility Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) has successfully finalized a loan agreement, securing a principal amount of up to US$35 million, approximately CDN$49 million, to bolster its development efforts. This financial support is aimed at facilitating a variety of pre-development activities, including...